Skip to content
Original
mp.weixin.qq.com·· 2 days agoScore76

BASF Raises Cash Offer for Evonik to 24 Euros Per Share

In brief

BASF raised its revised cash offer for Evonik to 24 euros per share, implying equity value of about 11 billion euros; the September offer of 22.15 euros per share had been rejected by Evonik. CEO Kamieth also pledged no operational layoffs before 2032, retention of management authority in Essen and North Rhine-Westphalia, autonomous operation of the Marl and Wesseling sites, and no divestment of Syneqt.

Source: mp.weixin.qq.com · mp.weixin.qq.com

#Deals & financing
CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org

Disclaimer CBA Frontier Insights uses AI-assisted methods to aggregate, summarize, and analyze publicly accessible biopharmaceutical information. Content is provided for informational and educational purposes only and does not represent the official views of original sources or affiliated organizations. AI-generated content may contain errors; please verify important information against primary sources. Intellectual property rights remain with their respective owners. For copyright concerns or corrections, please contact us through the website’s feedback page.